Genetic fusion of three tandem copies of murine C3d sequences to diphtheria toxin fragment B elicits a decreased fragment B-specific antibody response

Immunology Letters

Volumn 102, Issue 1, 2006, Pages 38-49

  Gor, Dennis O ^a,b   Ding, Xuedong ^a   Li, Qing ^a   Greenspan, Neil S ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antibody; C3d; Diphtheria toxin; Fusion proteins; Suppression

Indexed keywords

ANTIBODY; ANTIGEN; COMPLEMENT COMPONENT C3D; DIPHTHERIA TOXIN; GLYCOPROTEIN GP 120; INFLUENZA VIRUS HEMAGGLUTININ; LYSOZYME; POLYPEPTIDE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE FUSION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS; COMPLEMENT C3D; DIPHTHERIA TOXIN; FEMALE; GENE EXPRESSION; GENE FUSION; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS;

EID: 27744568318     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.06.020     Document Type: Article

References (23)

1. A.W. Griffioen, G.T. Rijkers, P. Janssens-Korpela, and B.J. Zegers Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2 Infect Immun 59 1991 1839 1845
2. P.W. Dempsey, M.E. Allison, S. Akkaraju, C.C. Goodnow, and D.T. Fearon C3d of complement as a molecular adjuvant: bridging innate and acquired immunity Science 271 1996 348 350
3. T.D. Green, B.R. Newton, P.A. Rota, Y. Xu, H.L. Robinson, and T.M. Ross C3d enhancement of neutralizing antibodies to measles hemagglutinin Vaccine 20 2001 242 248
4. T.D. Green, D.C. Montefiori, and T.M. Ross Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d J Virol 77 2003 2046 2055
5. D.J. Li, H.M. Wang, L. Li, X.R. Zhao, M.Y. Wang, Y. Zhu, Y. Meng, and M.M. Yuan Gene fusion of molecular adjuvant C3d to hCGβ enhances the anti-hCGb antibody response in DNA immunization J Reprod Immunol 60 2003 129 141
6. I. Watanabe, T.M. Ross, S. Tamura, T. Ichinohe, S. Ito, H. Takahashi, H. Sawa, J. Chiba, T. Kurata, T. Sata, and H. Hasegawa Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin Vaccine 21 2003 4532 4538
7. L. Wang, J.O. Sunyer, and L.J. Bello Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus J Virol 78 2004 1616 1622
8. S.T. Test, J. Mitsuyoshi, C.C. Connolly, and A.H. Lucas Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide Infect Immun 69 2001 3031 3040
9. R.H. Carter, and D.T. Fearon Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM J Immunol 143 1989 1755 1760
10. R.H. Carter, M.O. Spycher, Y.C. Ng, R. Hoffman, and D.T. Fearon Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes J Immunol 141 1988 457 463
11. K.M. Haas, F.R. Toapanta, J.A. Oliver, J.C. Poe, J.H. Weis, D.R. Karp, J.F. Bower, T.M. Ross, and T.F. Tedder Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression J Immunol 172 2004 5833 5837
12. J.S. Kim, and R.T. Raines Ribonuclease S-peptide as a carrier in fusion proteins Protein Sci 2 1993 348 356
13. D.O. Gor, X. Ding, Q. Li, J.R. Schreiber, M. Dubinsky, and N.S. Greenspan Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice Infect Immun 70 2002 5589 5595
14. J.D. Lambris, V.S. Ganu, S. Hirani, and H.J. Muller-Eberhard Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement Proc Natl Acad Sci USA 82 1985 4235 4239
15. L. Clemenza, and D.E. Isenman Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21) J Immunol 165 2000 3839 3848
16. G. Szakonyi, J.M. Guthridge, D. Li, K. Young, V.M. Holers, and X.S. Chen Structure of complement receptor 2 in complex with its C3d ligand Science 292 2001 1725 1728
17. P. Nizard, A. Chenal, B. Beaumelle, A. Fourcade, and D. Gillet Prolonged display or rapid internalization of the IgG-binding protein ZZ anchored to the surface of cells using the diphtheria toxin T domain Protein Eng 14 2001 439 446
18. T.M. Ross, Y. Xu, R.A. Bright, and H.L. Robinson C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge Nat Immunol 1 2000 127 131
19. S. Suradhat, R.P. Braun, P.J. Lewis, L.A. Babiuk, S. van Drunen Littel-van den Hurk, P.J. Griebel, and M.E. Baca-Estrada Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization Vet Immunol Immunopathol 83 2001 79 92
20. B. Heyman, E.J. Wiersma, and T. Kinoshita In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody J Exp Med 172 1990 665 668
21. S. Gustavsson, T. Kinoshita, and B. Heyman Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction J Immunol 154 1995 6524 6528
22. L. Chakravarty, M.D. Zabel, J.J. Weis, and J.H. Weis Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation Int Immunol 14 2002 139 146
23. E.S. Bergmann-Leitner, S. Scheiblhofer, R. Weiss, E.H. Duncan, W.W. Leitner, D. Chen, E. Angov, F. Khan, J.L. Williams, D.B. Winter, J. Thalhamer, J.A. Lyon, and G.C. Tsokos C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria Int Immunol 17 2005 245 255